FIGURE
Figure 4
- ID
- ZDB-FIG-220328-36
- Publication
- He et al., 2022 - Double-Sided Nano-ZnO: Superior Antibacterial Properties and Induced Hepatotoxicity in Zebrafish Embryos
- Other Figures
- All Figure Page
- Back to All Figure Page
Figure 4
Figure 4. Hepatotoxic effects of 125 nmol/mL Nano-ZnO on zebrafish. Live observation of zebrafish liver differences between the control group and the Nano-ZnO treatment group: (A) control group (250×), (B) control group (410×), (C) Nano-ZnO treatment group (250×), (D) Nano-ZnO treatment group (410×). H&E staining of zebrafish liver: (E) control group (410×), (F) Nano-ZnO treatment group (410×). Oil red staining of zebrafish liver steatosis: (G) control group (410×), (H) Nano-ZnO treatment group (410×). Picric acid-Sirius scarlet staining of zebrafish liver steatosis: (I) control group (410×), (J) Nano-ZnO treatment group (410×). (K) Liver development-related genes relative level of mRNA. (L) Liver disease-related genes relative level of mRNA ** p < 0.01.
|
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Toxics